Balance Sheet Details (Details) - USD ($) |
Mar. 31, 2022 |
Dec. 31, 2021 |
|---|---|---|
| Deferred offering costs | $ 2,600,000 | |
| Balance Sheet [Member] | ||
| Prepaid insurance | 455,592 | $ 769,416 |
| Prepaid external development costs | 138,810 | 0 |
| Prepaid other | 79,063 | 0 |
| Deferred offering costs | 179,592 | 55,718 |
| Total prepaid expenses | 853,057 | 825,134 |
| Accrued research and development costs | 245,174 | 235,384 |
| Accrued compensation and benefits | 155,272 | 766,207 |
| Accrued legal fees | 73,195 | 0 |
| Accrued board compensation | 55,625 | 0 |
| Total accrued and other current liabilities | $ 529,266 | $ 1,001,591 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets. No definition available.
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|